全文获取类型
收费全文 | 2284篇 |
免费 | 154篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 51篇 |
妇产科学 | 18篇 |
基础医学 | 413篇 |
口腔科学 | 49篇 |
临床医学 | 184篇 |
内科学 | 487篇 |
皮肤病学 | 43篇 |
神经病学 | 253篇 |
特种医学 | 49篇 |
外科学 | 223篇 |
综合类 | 3篇 |
预防医学 | 185篇 |
眼科学 | 20篇 |
药学 | 196篇 |
中国医学 | 6篇 |
肿瘤学 | 245篇 |
出版年
2024年 | 1篇 |
2023年 | 21篇 |
2022年 | 42篇 |
2021年 | 67篇 |
2020年 | 33篇 |
2019年 | 77篇 |
2018年 | 78篇 |
2017年 | 43篇 |
2016年 | 54篇 |
2015年 | 95篇 |
2014年 | 98篇 |
2013年 | 146篇 |
2012年 | 199篇 |
2011年 | 213篇 |
2010年 | 108篇 |
2009年 | 127篇 |
2008年 | 173篇 |
2007年 | 172篇 |
2006年 | 152篇 |
2005年 | 150篇 |
2004年 | 136篇 |
2003年 | 110篇 |
2002年 | 68篇 |
2001年 | 3篇 |
2000年 | 5篇 |
1999年 | 14篇 |
1998年 | 18篇 |
1997年 | 10篇 |
1996年 | 4篇 |
1995年 | 5篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 5篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 3篇 |
1977年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有2441条查询结果,搜索用时 15 毫秒
71.
Bruno Deltreggia Benites Carolina Silva Costa Lima Irene Lorand-Metze Marcia Torresan Delamain Gislaine Borba Oliveira Daiane de Almeida Carmino Antonio de Souza Jose Vassallo Katia Borgia Barbosa Pagnano 《Clinics (S?o Paulo, Brazil)》2013,68(3):339-343
OBJECTIVES:
To evaluate whether risk scores used to classify patients with primary myelofibrosis and JAK-2 V617F mutation status can predict clinical outcome.METHODS:
A review of clinical and laboratory data from 74 patients with primary myelofibrosis diagnosed between 1992 and 2011. The IPSS and Lille scores were calculated for risk stratification and correlated with overall survival.RESULTS:
A V617F JAK2 mutation was detected in 32 cases (47%), with no significant correlation with overall survival. The patients were classified according to the scores: Lille - low, 53 (73.%); intermediate, 13 (18%); and high, 5 (7%); and IPSS – low, 15 (26%); intermediate-1, 23 (32%); intermediate-2, 19 (26%); and high, 15 (31%). Those patients presenting a higher risk according to the IPSS (high and intermediate-2) had a significantly shorter overall survival relative to the low risk groups (intermediate-1 and low) (p = 0.02).CONCLUSIONS:
These results emphasize the importance of the IPSS prognostic score for risk assessment in predicting the clinical outcome of primary myelofibrosis patients. 相似文献72.
73.
Oren Rom Katia Avezov Dror Aizenbud Abraham Z. Reznick 《Respiratory physiology & neurobiology》2013,187(1):5-10
Despite the significant health risks resulting from tobacco use, the prevalence of smokers worldwide remains high. Cigarette smoking is one of the major sources of toxic chemical exposure to humans and is the greatest cause of preventable illnesses and premature death. The adverse consequences of smoking in various pathologies are mediated by its effects on the immune-inflammatory system. In this review, we aim to explore the effects of cigarette smoking on the inflammatory response and molecular mechanisms with emphasis on the nuclear factor kappa B (NF-kB) pathway. The effects of smoking on various inflammatory pathologies will be discussed, focusing on oral diseases, airway inflammation, chronic obstructive pulmonary disease (COPD) and inflammatory bowel diseases (IBD). 相似文献
74.
75.
76.
B Rodrigues L Jorge CT Mostarda KT Rosa A Medeiros C Malfitano AL de Souza KA Viegas S Lacchini R Curi PC Brum K De Angelis MC Irigoyen 《Journal of cardiac failure》2012,18(9):734-744
BackgroundExercise training (ET) has been used as a nonpharmacological strategy for treatment of diabetes and myocardial infarction (MI) separately. We evaluated the effects ET on functional and molecular left ventricular (LV) parameters as well as on autonomic function and mortality in diabetics after MI.Methods and ResultsMale Wistar rats were divided into control (C), sedentary-diabetic infarcted (SDI), and trained-diabetic infarcted (TDI) groups. MI was induced after 15 days of streptozotocin-diabetes induction. Seven days after MI, the trained group underwent ET protocol (90 days, 50-70% maximal oxygen consumption-VO2max). LV function was evaluated noninvasively and invasively; baroreflex sensitivity, pulse interval variability, cardiac output, tissue blood flows, VEGF mRNA and protein, HIF1-α mRNA, and Ca2+ handling proteins were measured. MI area was reduced in TDI (21 ± 4%) compared with SDI (38 ± 4%). ET induced improvement in cardiac function, hemodynamics, and tissue blood flows. These changes were probable consequences of a better expression of Ca2+ handling proteins, increased VEGF mRNA and protein expression as well as improvement in autonomic function, that resulted in reduction of mortality in TDI (33%) compared with SDI (68%) animals.ConclusionsET reduced cardiac and peripheral dysfunction and preserved autonomic control in diabetic infarcted rats. Consequently, these changes resulted in improved VO2max and survival after MI. 相似文献
77.
78.
Katia Sindali Barry Rose Hassan Soueid Parminder Jeer Deepak Saran Raj Shrivastava 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2013,23(4):481-486
Introduction
Rivaroxaban is the first licensed oral direct inhibitor of factor Xa. Recent studies from the RECORD trials suggest rivaroxaban has superior efficacy compared to enoxaparin in preventing venous thromboembolism (VTE) with no significant increase in the major bleeding risk. Concerns remain regarding the incidence of minor bleeding, consequent delayed wound healing and subsequent risk of infection. The aim of this observational study was to assess the incidence of post-operative complications in patients receiving either rivaroxaban or enoxaparin thromboprophylaxis following elective hip and knee arthroplasty.Methods
A total of 258 patients undergoing elective total hip or knee arthroplasty within one NHS Trust were included. A total of 202 subjects (mean age, 70.7 years ± 10.0, 43 % men) received a daily dose of 10 mg of oral rivaroxaban and 56 (mean age, 70.9 years ± 9.8, 39 % men) had a daily subcutaneous injection of 40 mg of enoxaparin as thromboprophylaxis. Endpoints included VTE (deep vein thrombosis and pulmonary embolism), haemorrhagic wound complications, hospital re-admission, requirement for blood transfusion, minor and major bleeding and death.Results
There were no significant differences in the incidence of VTE, requirement for blood transfusion and readmission rate between rivaroxaban and enoxaparin-treated patients. The incidence of minor bleeding (2.0 vs. 0 %) and haemorrhagic wound complications (5.0 vs. 1.8 %) were non-significantly higher in the rivaroxaban-treated group. There were no cases of pulmonary embolism, major bleeding or death in either group.Conclusion
Our experience with rivaroxaban in elective hip and knee arthroplasty showed no significant difference in the incidence of VTE or major bleeding. There was, however, a tendency to greater risk of minor bleeding and wound complications that were largely haemorrhagic in nature, which may have reached significance in a larger study. 相似文献79.
80.